2026-09-26T11:52:37Zhttps://api.repository.cam.ac.uk/server/oai/request

oai:www.repository.cam.ac.uk:1810/3703792024-07-13T00:43:23Zcom_1810_245118com_1810_34581col_1810_245119

Effect of platinum chemotherapy on tumour infiltrating immune cells in metastatic ovarian cancer: Mechanistic insights and therapeutic applications https://doi.org/10.17863/CAM.109815 Boyles, Christabel Halim, Timotheus Platinum chemotherapeutics remain standard of care for many cancer patients, including high grade serous ovarian cancer. It is becoming clear that chemotherapy can initiate adaptive immune responses to the cancer, however, it remains unclear to what extent innate Natural Killer (NK) cells contribute. Using two syngeneic models (UPK10 and ID8p53^-/-) of metastatic ovarian cancer this thesis found that treatment with carboplatin upregulates NK cell activating receptor ligands, induced a pro-inflammatory phenotype and sensitised tumour cells to NK cell mediated cytotoxicity. *In vivo*, carboplatin therapy was dependent on the presence of NK cells and CD8⁺ T cells and treatment with carboplatin resulted in an enrichment for NK cells and CD8⁺ T cells within the tumour. This effect however was model dependent. Therapeutically, Il-15/IL-15Rα treatment increased the numbers of cytotoxic NK cells at sites of metastasis, which significantly reduced tumour burdens in mice when used in combination with carboplatin. Collectively, these findings demonstrated the importance of NK cells as mediators of standard cancer therapy and represents an attractive and relatively safe therapeutic target for combination therapy. University of Cambridge 2023-12-22 Thesis Doctoral Doctor of Philosophy (PhD) eng https://www.repository.cam.ac.uk/handle/1810/370379 https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/4e3f0323-4bf8-4b5d-91bc-6389b9a7e0f4/download b5ad1938ba4dddb7d8609e12e97a1cf2 https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/f2d2d0b2-ed87-4231-bce4-20db99931edc/download 87eda9de84448d1f82354d60eee3eb5f https://www.rioxx.net/licenses/all-rights-reserved/ Carboplatin High-grade serous ovarian cancer Natural killer cells